Patents by Inventor Geeta Patel

Geeta Patel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oral care compositions for combatting dental erosion
    Patent number: 9259379
    Abstract: A oral care composition comprising a triple polymer system and a source of fluoride ions for combating (i.e. helping to prevent, inhibit and/or treat) dental erosion and/or tooth wear is described. Such compositions are also of use in combating dental caries.
    Type: Grant
    Filed: June 28, 2013
    Date of Patent: February 16, 2016
    Assignee: Glaxo Group Limited
    Inventors: Ruth Corcoran-Henry, Soha Dattani, Christabel Fowler, Geeta Patel
  • Novel Use
    Publication number: 20140037556
    Abstract: A oral care composition comprising a triple polymer system and a source of fluoride ions for combating (i.e. helping to prevent, inhibit and/or treat) dental erosion and/or tooth wear is described. Such compositions are also of use in combating dental caries.
    Type: Application
    Filed: June 28, 2013
    Publication date: February 6, 2014
    Inventors: Ruth CORCORAN-HENRY, Soha Dattani, Christabel Fowler, Geeta Patel
  • NOVEL USE
    Publication number: 20110256074
    Abstract: A oral care composition comprising a triple polymer system and a source of fluoride ions for combating (i.e. helping to prevent, inhibit and/or treat) dental erosion and/or tooth wear is described. Such compositions are also of use in combating dental caries.
    Type: Application
    Filed: December 7, 2009
    Publication date: October 20, 2011
    Applicant: Glaxo Group Limited
    Inventors: Ruth Corcoran-Henry, Soha Dattani, Christabel Fowler, Geeta Patel
  • Platelet-derived growth factor analogues
    Patent number: 6350731
    Abstract: Novel peptide analogues of platelet-derived growth factor, for use in inhibiting or stimulating growth and/or chemotaxis of cells, for example, smooth muscle cells, are provided. Also provided are compositions of matter comprising those peptide analogues.
    Type: Grant
    Filed: November 2, 1999
    Date of Patent: February 26, 2002
    Assignee: Trigen Limited
    Inventors: Ahmed Mohammed Taki Jehanli, Geeta Patel, Yemisi Olabiran, David Mark Brennand, Vir Vijay Kakkar
  • Serine protease inhibitors
    Patent number: 6127340
    Abstract: This invention is directed to peptide inhibitors of serine proteases, espcecially thrombin, in which the P1-P2 natural amide linkage is replaced by another bond. Exemplary thrombin inhibitors have the formula: X-(aa.sup.3)-(aa.sup.2)-.psi.-(aa.sup.1)-Z wherein X is H or a substituent on the N-terminal amino group, aa.sup.3 is a hydrophobic amino acid, aa.sup.23 is Pro, aa.sup.1 is Arg or an Arg analgoue, Z is --COOH or a heteroatom acid group and .psi. is a non-amide linkage.
    Type: Grant
    Filed: March 30, 1998
    Date of Patent: October 3, 2000
    Assignee: Trigen Limited
    Inventors: Donovan St. Clair Green, Said Mohammed Anwr Ahmed Elgendy, Geeta Patel, Michael Finbar Scully, Christopher Andrew Goodwin, Vijay Vir Kakkar, John Joseph Deadman
  • Platelet-derived growth factor analogues
    Patent number: 6001802
    Abstract: This invention relates to cyclic platelet-derived growth factor (PDGF) analogues and pharmaceutical compositions thereof.
    Type: Grant
    Filed: July 7, 1998
    Date of Patent: December 14, 1999
    Assignee: Trigen Limited
    Inventors: Taki Ahmed Mohammed Jehanli, Geeta Patel, Yemisi Olabiran, Mark David Brennand, Vir Vijay Kakkar
  • Platelet-derived growth factor analogues
    Patent number: 5952304
    Abstract: Novel peptide analogues of platelet-derived growth factor, for use in inhibiting or stimulating growth and/or chemotaxis of cells, e.g., smooth muscle cells, are provided. Also provided are compositions of matter comprising those peptide analogues.
    Type: Grant
    Filed: April 19, 1996
    Date of Patent: September 14, 1999
    Assignee: Trigen Limited
    Inventors: Ahmed Mohammed Taki Jehanli, Geeta Patel, Yemisi Olabiran, David Mark Brennand, Vir Vijay Kakkar
  • Boric ester synthesis
    Patent number: 5596123
    Abstract: Stable .alpha.-substituted boronic esters, e.g. for use in peptide synthesis, are prepared by reacting a substituted alkene of the formula: ##STR1## with a disubstituted borane of the formula: ##STR2## wherein: (i) R.sup.1 and R.sup.2 are each selected from various groups which are preferably not leaving groups;(ii) X is halogen or other leaving group;(iii) Y is H or lower alkyl;(iv) Q.sup.1 and Q.sup.2 are each selected from various groups which are preferably such that the borane is non-hydrolyzable, and particularly Q.sup.1 and Q.sup.2 together may represent a residue of a diol such as catechol or pinanediol.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: January 21, 1997
    Assignee: Thrombosis Research Institute
    Inventors: Said M. A. Elgendy, John J. Deadman, Geeta Patel, Donovan S. Green, Jehan A. Baban, Vijay V. Kakkar, Goran K. Claeson